[ad_1]
Zooming in additional, there’s one explicit sort of insulating materials positioned between the chip and the construction beneath it; this materials, referred to as dielectric movie, is produced in sheets as skinny as white blood cells.
For 30 years, a single Japanese firm referred to as Ajinomoto has made billions producing this explicit movie. Rivals have struggled to outdo them, and at the moment Ajinomoto’s merchandise are utilized in all the things from laptops to knowledge facilities.
Now, a startup primarily based in Berkeley, California, is embarking on a herculean effort to dethrone Ajinomoto and convey this small slice of the chipmaking provide chain again to the US. However success is much from assured. Learn the total story.
—James O’Donnell
The trouble to make a breakthrough most cancers remedy cheaper
CAR-T therapies, created by engineering a affected person’s personal cells to battle most cancers, are usually reserved for individuals who have exhausted different therapy choices. However final week, the FDA accredited Carvykti, a CAR-T product for a number of myeloma, as a second-line remedy. Which means persons are eligible to obtain Carvykti after their first relapse.
Whereas this implies some a number of myeloma sufferers within the US will now get earlier entry to CAR-T, the overwhelming majority of sufferers across the globe nonetheless gained’t get CAR-T in any respect. These therapies are costly—half one million {dollars} in some instances. However have they got to be? Learn the total story.
[ad_2]
